These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8769151)

  • 1. Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720.
    Suzuki S; Li XK; Shinomiya T; Enosawa S; Kakefuda T; Mitsusada M; Amemiya H; Takahara S; Amari M; Naoe S; Hoshino Y; Chiba K
    Transplant Proc; 1996 Aug; 28(4):2049-50. PubMed ID: 8769151
    [No Abstract]   [Full Text] [Related]  

  • 2. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
    Kawaguchi T; Hoshino Y; Rahman F; Amano Y; Higashi H; Kataoka H; Ohtsuki M; Teshima K; Chiba K; Kakefuda T; Suzuki S
    Transplant Proc; 1996 Apr; 28(2):1062-3. PubMed ID: 8623227
    [No Abstract]   [Full Text] [Related]  

  • 3. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
    Liu L; Wang C; He X; Shang W; Bi Y; Wang D
    Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
    Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment.
    Azuma H; Takahara S; Horie S; Muto S; Otsuki Y; Katsuoka Y
    J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor pretreatment with FTY720 increases graft lymphocytes but does not affect graft survival following rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transplant Proc; 2002 May; 34(3):973-4. PubMed ID: 12034266
    [No Abstract]   [Full Text] [Related]  

  • 13. A high-capacity quantitative mouse model of drug-mediated immunosuppression based on rejection of an allogeneic subcutaneous tumor.
    Hammond-McKibben D; Lake P; Zhang J; Tart-Risher N; Hugo R; Weetall M
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1144-51. PubMed ID: 11356940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K
    Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.
    Sugito K; Inoue M; Ikeda T; Hagiwara N; Koshinaga T; Kusafuka T
    Transplant Proc; 2007 Dec; 39(10):3432-5. PubMed ID: 18089399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft.
    Ubai T; Azuma H; Kotake Y; Inamoto T; Takahara K; Ito Y; Kiyama S; Sakamoto T; Horie S; Muto S; Takahara S; Otsuki Y; Katsuoka Y
    Anticancer Res; 2007; 27(1A):75-88. PubMed ID: 17352219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
    Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats.
    Suzuki S; Enosawa S; Kakefuda T; Li XK; Mitsusada M; Takahara S; Amemiya H
    Transpl Immunol; 1996 Sep; 4(3):252-5. PubMed ID: 8893458
    [No Abstract]   [Full Text] [Related]  

  • 19. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.
    Chiba K; Hoshino Y; Suzuki C; Masubuchi Y; Yanagawa Y; Ohtsuki M; Sasaki S; Fujita T
    Transplant Proc; 1996 Apr; 28(2):1056-9. PubMed ID: 8623225
    [No Abstract]   [Full Text] [Related]  

  • 20. The thymus is required for the ability of FTY720 to prolong skin allograft survival across different histocompatibility MHC barriers.
    del Rio ML; Pabst O; Ramirez P; Penuelas-Rivas G; Förster R; Rodriguez-Barbosa JI
    Transpl Int; 2007 Oct; 20(10):895-903. PubMed ID: 17854447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.